rTAP (DuPont Pharmaceuticals)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NamerTAP (DuPont Pharmaceuticals)
Drug Alias NameTAP (Merck Sharpe and Dohme)TAP (DuPont Pharmaceuticals)tick-derived anticoagulant peptiderTAP (Merck Sharpe and Dohme)TAP
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsBlood Coagulation DisordersThromboembolismAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Research Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma CompanyMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsBlood Coagulation DisordersThromboembolismAngina Pectoris

Other Information

ATC CodeN/A
Related LinksN/A